JP2024537178A5 - - Google Patents
Info
- Publication number
- JP2024537178A5 JP2024537178A5 JP2024520883A JP2024520883A JP2024537178A5 JP 2024537178 A5 JP2024537178 A5 JP 2024537178A5 JP 2024520883 A JP2024520883 A JP 2024520883A JP 2024520883 A JP2024520883 A JP 2024520883A JP 2024537178 A5 JP2024537178 A5 JP 2024537178A5
- Authority
- JP
- Japan
- Prior art keywords
- malignant neoplasms
- fusion protein
- cancer
- protein according
- neoplasms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163253759P | 2021-10-08 | 2021-10-08 | |
| US63/253,759 | 2021-10-08 | ||
| PCT/US2022/077779 WO2023060248A1 (en) | 2021-10-08 | 2022-10-07 | Compositions and methods for the treatment of p53-mediated cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024537178A JP2024537178A (ja) | 2024-10-10 |
| JP2024537178A5 true JP2024537178A5 (cg-RX-API-DMAC7.html) | 2025-10-14 |
Family
ID=83995572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024520883A Pending JP2024537178A (ja) | 2021-10-08 | 2022-10-07 | p53媒介性癌の処置のための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240400626A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4413023A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024537178A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118488962A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3234720A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023060248A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119684450B (zh) * | 2024-12-25 | 2025-08-05 | 无锡傲锐东源生物科技有限公司 | 抗人bcor蛋白单克隆抗体及其杂交瘤细胞株和应用 |
| CN120966914B (zh) * | 2025-10-21 | 2025-12-23 | 曲阜师范大学 | 一种中华蜜蜂DnaJC28基因及其编码蛋白和应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8918616D0 (en) | 1989-08-15 | 1989-09-27 | Univ Glasgow | Herpes simplex virus type 1 mutant |
| US5804413A (en) | 1992-07-31 | 1998-09-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Herpes simplex virus strains for gene transfer |
| GB9415319D0 (en) | 1994-07-29 | 1994-09-21 | Medical Res Council | HSV viral vector |
| US5846782A (en) | 1995-11-28 | 1998-12-08 | Genvec, Inc. | Targeting adenovirus with use of constrained peptide motifs |
| US6093570A (en) | 1995-06-07 | 2000-07-25 | The University Of North Carolina At Chapel Hill | Helper virus-free AAV production |
| US6013516A (en) | 1995-10-06 | 2000-01-11 | The Salk Institute For Biological Studies | Vector and method of use for nucleic acid delivery to non-dividing cells |
| EP1002119A1 (en) | 1997-07-31 | 2000-05-24 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Targeted hsv vectors |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| DE69939169D1 (de) | 1998-05-28 | 2008-09-04 | Us Gov Health & Human Serv | Aav5 vektoren und deren verwendung |
| US6630584B1 (en) * | 2000-03-16 | 2003-10-07 | Ramot At Tel-Aviv University Ltd. | Single chain antibody against mutant p53 |
| US7465583B2 (en) | 2000-06-01 | 2008-12-16 | The University Of North Carolina At Chapel Hill | Duplexed parvovirus vectors |
| WO2002053703A2 (en) | 2001-01-05 | 2002-07-11 | Children's Hospital, Inc. | Aav2 vectors and methods |
| CN103589692B (zh) | 2001-11-13 | 2018-07-24 | 宾夕法尼亚大学托管会 | 检测和/或鉴定腺伴随病毒(aav)序列以及分离所鉴定的新型序列的方法 |
| DK2359869T3 (en) | 2001-12-17 | 2019-04-15 | Univ Pennsylvania | Sequences of adeno-associated virus (AAV) serotype 8, vectors containing these, and uses thereof |
| GB0210746D0 (en) * | 2002-05-10 | 2002-06-19 | Medical Res Council | Peptide |
| EP1668143B1 (en) | 2003-09-30 | 2013-03-20 | The Trustees of The University of Pennsylvania | Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| EP1828390B1 (en) | 2004-12-15 | 2012-06-13 | The University Of North Carolina At Chapel Hill | Chimeric vectors |
| EP2396343B1 (en) | 2009-02-11 | 2017-05-17 | The University of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
| US9169494B2 (en) | 2010-01-12 | 2015-10-27 | The University Of North Carolina At Chapel Hill | Restrictive inverted terminal repeats for viral vectors |
| WO2011097456A2 (en) | 2010-02-05 | 2011-08-11 | The University Of North Carolina At Chapel Hill | Compositions and methods for enhanced parvovirus transduction |
| WO2014053879A1 (en) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Cell penetrating peptides for intracellular delivery of molecules |
| EP2929045B1 (en) * | 2012-12-05 | 2020-12-02 | SOLA Biosciences LLC | Protein expression enhancing polypeptides |
-
2022
- 2022-10-07 WO PCT/US2022/077779 patent/WO2023060248A1/en not_active Ceased
- 2022-10-07 EP EP22794080.6A patent/EP4413023A1/en active Pending
- 2022-10-07 CN CN202280081375.8A patent/CN118488962A/zh active Pending
- 2022-10-07 US US18/698,820 patent/US20240400626A1/en active Pending
- 2022-10-07 JP JP2024520883A patent/JP2024537178A/ja active Pending
- 2022-10-07 CA CA3234720A patent/CA3234720A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Russell et al. | Measles virus for cancer therapy | |
| US10780096B2 (en) | Pyrrolobenzodiazepine-antibody conjugates | |
| ES2871001T3 (es) | Conjugados de pirrolobenzodiazepinas y anticuerpos | |
| JP2021506883A (ja) | ピロロベンゾジアゼピン抗体結合体 | |
| EA020324B1 (ru) | АНТИТЕЛА К РЕЦЕПТОРУ ЭФРИНА EphA2 И ИХ ПРИМЕНЕНИЕ | |
| US20200197536A1 (en) | Porous nanoparticle-supported lipid bilayer delivery of transcriptional gene modulators | |
| JP2023089103A5 (cg-RX-API-DMAC7.html) | ||
| JP2025509290A (ja) | Pcna阻害剤及びその使用 | |
| JP2022169780A5 (cg-RX-API-DMAC7.html) | ||
| WO2002039117A1 (en) | Methods for the treatment of cellular proliferative disorders | |
| Bulatova et al. | Toward a topology-based therapeutic design of membrane proteins: Validation of NaPi2b topology in live ovarian cancer cells | |
| WO2020211847A1 (zh) | 替加色罗在制备抗肿瘤药物中的应用 | |
| JP2020521786A5 (cg-RX-API-DMAC7.html) | ||
| JP2011524355A5 (cg-RX-API-DMAC7.html) | ||
| Sanchez et al. | Solitary extramedullary plasmacytoma of the head and neck: A report of three cases treated with curative radiotherapy and a review of the dose-control relationship | |
| KR102495245B1 (ko) | 피롤로벤조디아제핀-항체 컨쥬게이트 | |
| CN113677340A (zh) | 作为抗癌药物的选择性且有效抑制Hakai介导的泛素化的化合物 | |
| CN117959423A (zh) | 用于治疗和/或预防癌症的单克隆抗体及其相关产品 | |
| ElKashty | Effectiveness of sulforaphane in increasing drug mediated cytotoxicity toward cancer stem cells in head and neck squamous cell carcinoma | |
| US11597774B2 (en) | Antibody variable domains and antibody constructs | |
| WO2013157648A1 (ja) | 医薬組成物 | |
| RASHEED et al. | Solitary Extramedullary Plasmacytoma of the Thyroid Cartilage: A Case Report. | |
| JP2007501259A (ja) | 頭頸部がんの処置 | |
| ES2613031T3 (es) | Compuestos antiproliferativos y su utilización | |
| RU2718048C2 (ru) | Противоопухолевое терапевтическое средство |